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 Betel quid (BQ) chewing is a popular habit in Taiwan, India and many 
Southeast Asian countries 1. It has been estimated that, worldwide, around 600 million 
people chew areca nut 2. Areca nut popularly known as betel nut accounts for a major 
portion, by weight of the betel quid, which is composed of betel leaf, areca nut, 
catechu and lime to which tobacco may or may not be added 3. Condiments, 
sweetening agents and spices maybe added according to individual preferences 4.  
 Betel leaf is perishable and BQ preparation is complex, and this led to the 
emergence of commercial areca nut products about three decades ago. In India, areca 
nut is chewed as such or in the form of commercial products such as scented supari, 
manipuri tobacco, pan masala (areca quid, catechu, lime, flavors and spice), gutka or 
mawa (areca quid and tobacco) 4,5.  
  Oral submucous fibrosis is a pre-malignant and crippling condition of the oral 
mucosa characterized by submucosal fibrosis leading to atrophic changes in the 
epithelium resulting in mucosa appearing pale or whitish, presence of palpable fibrous 
bands, sensitivity to hot and spicy food and restricted mouth opening6. 
  Oral submucous fibrosis was first described by Schwartz in 1952 among five 
East African women of Indian origin. This was followed by first description of this 
condition in India in 1953 by Lal and Joshi 5. 
  The overall prevalence of OSF has increased from 2.42 in 2002 to 6.42 per 
1000 per year in 20047. Rapid onset of the disease in younger chewers has been 
reported in a hospital based case control study in Chennai, South India8. 
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Several studies concerning the etiologic factors of OSF have been done but not 
many focusing on the habitual use of different forms of areca nut. Areca nut contains 
several alkaloids of which arecoline is the most abundant.  Many of the undesirable 
effects of areca nut have been attributed to arecoline because of its mutagenic activity 
in mammalian cells. Arecoline is also a cytotoxic agent to primary human buccal 
fibroblast cultures. Paradoxically, it has been experimentally observed that arecoline 
in lower concentrations stimulates collagen synthesis by fibroblasts in vitro 4, 5. 
Strong association between areca nut use and OSF has been studied but not 
many have been done to assess the effects of alkaloids derived from products at a 
cellular level. Hence, the present study was done to isolate, culture and characterize 
fibroblasts from buccal mucosa of subjects without areca nut chewing habit and to 
evaluate the changes in the cultured fibroblast cells when exposed to extracts of 
various commercial areca nut products.  
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Aims and Objectives 
 
I. To isolate and culture fibroblasts from the buccal mucosa of subjects who 
do not chew areca nut and have clinically normal appearing oral mucosa.  
II. To evaluate the effects of commonly used areca nut products on the 
cultured fibroblast cells. 
III. To evaluate and compare the following features 
 
• The ratios between F1, F2, F3 subpopulations. 
• The ratios between mitotic and post-mitotic phenotypes. 
• The growth curve and its derivatives for each cell line. (Seeding efficiency 
and population doubling time). 
 
 
Hypothesis 
Areca nut products can alter the phenotypic characteristics of buccal mucosal 
fibroblasts. 
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History 
The practice of betel quid or areca nut chewing dates back several thousand 
years. A ceremonial gift of dried tobacco leaves given to Columbus by native 
Americans in 1492 led to the introduction of tobacco into the rest of the world. It 
arrived in India in the 16th century when a sample of dried tobacco was presented to 
Emperor Akbar who patronized smoking. BQ chewing was already a socially well 
accepted practice and the introduction of tobacco reinforced this practice. An attempt 
to ban the rapidly spread habit of smoking in 1619 had little effect as the revenue 
from tobacco was already considerable4. 
The preparation of BQ varies in different countries. In India the BQ generally 
contains areca nut, lime, tobacco with or without piper betel leaf (PBL) whereas a 
piece of piper betel inflorescence is used instead of tobacco in the typical BQ 
preparation in Taiwan and Papua New Guinea2. 
Betel leaf being perishable and the preparation of BQ being complex, resulted 
in the evolution of commercial substitutes like pan masala and gutka about three 
decades ago. The products were made available in the market in 1985 as 4gm sachets. 
The website (www.newindia.com/kothari/) of the first major manufacturer of pan 
masala and gutka presented their strategy as ‘….to prepare convenient, anytime, 
anywhere substitute for pan….give some respectability to a habit that was considered 
low in image by genteel’4. 
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Sushruta- the ancient Indian medical text- describes a condition termed 
‘VIDARI’ under mouth and throat diseases as ‘progressive narrowing of mouth, 
depigmentation of oral mucosa and pain on taking food’ which are the typical 
characteristic features of OSF 6. In 1952, Schwartz described five Indian from Kenya 
with a condition of oral mucosa including the palate and the pillars of the fauces, 
which he called “atrophia idiopathica (tropica) mucosae oris”. Other names are 
“diffuse oral submucous fibrosis”, “idiopathic scleroderma of mouth”, “idiopathic 
palatal fibrosis”, “sclerosing stomatitis” and “juxta-epithelial fibrosis”. Later it was 
termed “oral submucous fibrosis (OSF)”14.  
The malignant potential of this condition was first described by Paymaster15. 
The first description of this condition in India was in 1953 by Lal and Joshi. The first 
report among non-Indians was from Taiwan by Su in 19545. A strong association 
between areca nut use and oral submucous fibrosis has been established 10. 
Only sporadic cases of OSF were reported during 1960’s and 1970’s.In 1980 
Pindborg found that there were 250,000 OSF cases in India. In 1993 Phatak AG 
estimated the OSF cases in India to be two million. This is an eight-fold increase in 
the oral submucous fibrosis cases in less than 15 years6.   
 
 
 
 
 
 
 
15 
 
Epidemiology 
 
Shah N and Sharma P.P (1998) performed a case control study on 236 patients who 
belonged to New Delhi, to identify the relationship of various chewing and smoking 
habits to the development of OSF. They found that maximum number of OSF cases 
belonged to the age group of 21 to 30 years, with a male to female ratio of 2.2:1. Also, 
in the younger age group of 11-20 years, males were found to be more affected, the 
proportion being 6.5:1. It was also seen that 75% of the pan masala chewers took 4.6 
years to develop the disease while quid chewers took 9.6 years to develop the disease. 
The overall effect of pan masala chewing when compared to quid chewing clearly 
showed that pan masala chewers developed the disease in almost half the time taken 
by nut/quid chewers. The relative risk to develop the disease was found to increase 
with the frequency of chewing rather than the duration of chewing. The role of 
tobacco in the development of the disease was not significant.6 
 
Ranganathan K, Uma Devi M, Joshua E, Kriankumar K, Saraswathi T R (2004) 
carried out a case control study among 185 OSF patients in Chennai.  Areca nut and 
pan masala were found to be more widely used than betel quid. More males used pan 
masala than females. Eight percent of the controls had chewing habits but their mean 
duration of usage was 3 years as compared to 6 years of the OSF cases. The highest 
risk of developing disease was for pan masala chewers followed by pan masala and 
alcohol users. When compared to them, betel quid chewers were found to have a 
reduced risk. Tobacco smoking and use of alcohol without use of areca nut products 
was not associated with OSF. The risk of developing OSF was double for patient 
below 21, who developed the disease within 3.5 years of having the habit compared to 
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patients of age 21 to 40 years who took 6.5 years of chewing habit to develop the 
disease.8 
 
Yang Y.H, Lein Y-C, Ho P-S, Chen C.H, Chang J.S.F, Cheng T.C and Sheih T.Y 
(2005) conducted a study to investigate the risk of areca /betel quid chewing with and 
without cigarette smoking on OSF patients. A stratified case-control study was 
designed in the Taiwanese population in which they selected 102 patients with oral 
mucosal lesions of which 62 were diagnosed of having OSF. The areca/betel quid 
consumed in Taiwan has never contained tobacco. OSF was the most prevalent lesion 
in every combination of areca betel quid chewing and smoking habits (60.8%) 
followed by hyperkeratosis (39.2%) which was prevalent in chewing without smoking 
group.  Cases of oral squamous cell carcinomas were seen in the quid only group. 
When 62 OSF patients were analyzed, people with smoking and areca nut chewing 
had a statistically significant odds ratio of 8.68 whereas in people with areca nut 
chewing and no smoking the odds ratio was 4.51.16 
 
Pei-Shan HO, Yi-Hesin Yang, Tein-Yu Shieh, I-Yueh, Yun-Kwan Chen, Ko-Ni 
Lin et al (2006) carried out a case control study to identify the effects of areca nut, 
smoking and alcohol consumption on the coexistence of OSF and oral cancer. 104 
histologically confirmed male OSF subjects were included, which consisted of 65 
OSF subjects without oral cancer (control group) and 39 OSF subjects with oral 
cancer (case group). Age and consumption of alcoholic beverages showed a 
significant effect and the odds ratio were 1.07 in age and 1.5 in alcohol consumption. 
It was found that older age and increase in consumption of alcohol might be important 
malignant risk factors for oral cancer and OSF. Alcohol consumption was 
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significantly higher in patients having OSF with squamous cell carcinoma when 
compared to patients with OSF alone or along with the use of tobacco. Using 
regression models it was found that age and use of alcohol had a significant effect on 
malignant transformation of OSF. 17 
 
Hazarey V.K, Erlewad D.M, Mundhe K.A and Ughade S.N (2007) conducted a 
cross-sectional study to correlate the gender specificity for the different habits and 
severity of OSF. OSF occurred in younger men when compared to women, with the 
male to female ratio for occurrence of OSF being 4.9:1. Exclusive areca chewing was 
more prevalent with females. 77.8% of the OSF patients had multiple habits while 
20.5% had exclusive areca chewing habit. The associated lesions with OSF were 
leukoplakia (4.8%), lichen planus (0.7%), erythroplakia (0.2%), betel chewers mucosa 
(0.7%) and squamous cell carcinoma (3.3%). 7 
 
Hsue Shue-Shue, Wang Wen-Chen, Chen Chung-Ho, Lin Cheng-Chung, Chen 
Yun-Kan and Lin Min-Lin (2007) carried out a follow up study to estimate the rate 
and time of transformation for various potentially malignant oral mucosal lesions in a 
Taiwanese population. The follow up time was defined as the duration between the 
onset of the initial diagnosis and the occurrence of confirmed oral cancer. A total of 
1458 patients with histological diagnosis of various potentially malignant oral 
mucosal disorders were followed up for a period from 1991 to 2001. Amongst these 
1458 patients with various potentially malignant oral epithelial lesions, 44 patients 
were found to progress to oral carcinoma proper giving an overall transformation rate 
of 3.02% and a mean time for transformation of 42.6 months. It was also found that 
18 
 
there was a malignant transformation rate of 1.9 % with a median duration of 52.3 
months among the OSF patients. 18 
 
Etiology 
OSF is a precancerous condition with a high risk for cancer development. The use of 
chilies (Capsicum annum and Capsicum frutescens) was suggested as possible 
etiological factors but currently the habit of areca nut chewing is recognized as the 
most important etiologic agent in the pathogenesis of this condition 19.  
Several epidemiological studies have shown that areca nut is the etiological 
factor for oral submucous fibrosis20. A definite dose dependent relationship between  
areca nut consumption and causation of the disease exist. Frequency and duration of 
areca nut use are important in the disease causation 8.  
 
Areca nut: 
Areca nut (often referred as betel nut) is the endosperm of the fruit of the Areca 
catechu tree. The areca palm is native to South Asia and Pacific islands. The fruit is 
orange-yellow in colour when ripe. The fibrous pericarp is removed from the seed or 
endosperm, which then used fresh, after sun-drying or in a cured form.  
Areca nut contains tannins (11.4-26%) of which gallotannic acid (18.03%) and D-
Catechol (0.4%) are important. It contains several alkaloids (0.15-0.67%) like 
arecoline and arecaidine, of which arecoline is the most abundant1, 2, 5,21.  
The pharmacologic effects of areca nut include addiction, euphoria, excessive 
salivation and tremor, attributable to the parasympathomimetic action of arecoline, the 
major alkaloid of areca nut 22. 
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Various areca nut preparations used in the Indian subcontinent are7 
a) Supari – Areca nut alone 
b) Betel quid- Areca nut, tobacco, betel leaf, slaked lime. 
c) Mawa -Thin shavings of areca nut with some sun dried tobacco and slaked  
lime. 
d) Gutka – Areca nut, powdered tobacco, catechu, condiments and slaked lime. 
e) Panmasala – Areca nut, catechu, condiments and slaked lime.  
 
Pathogenesis 
The pathogenesis of OSF is believed to be multifactorial, triggering the disease by 
causing juxtaepithelial inflammatory reactions resulting in fibrosis of the oral mucosa. 
The fibrosis could be due to abnormal collagen, increased collagen production or 
decreased collagen destruction. Overall increased production and decreased 
degradation of collagen results in increased collagen deposition on the oral tissues, 
leading to fibrosis. This phenomenon is due to up regulation or down regulation of 
various pathways involved in the collagen turnover. The fibrosis of the sub-epithelial 
connective tissue accounts for the various clinical features found in OSF. 
Initial events 
When the betel quid is placed in the buccal vestibule for 15 minutes to one hour and 
repeated five to six times, alkaloids and flavonoids from the quid are absorbed into 
the oral mucosa and are metabolized facilitated by constant contact between the 
mixture and the oral tissues. These constituents along with the physical micro trauma 
produced by the areca nut leads to a juxta-epithelial inflammatory cell infiltrate. Over 
a period of time due to the persistence of the habit, chronic inflammation sets in 
followed by atrophy and ulceration of the mucosa. 23 
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The inflammatory cells within the lesional tissue consist mainly of T 
lymphocytes with a high CD4:CD8 ratio. Studies have shown an increase in pro-
fibrotic cytokines like IL-6 IL-1, TGF-β, PDGF at lesional site of OSF and an 
accompanied down regulation of anti-fibrotic cytokines like IFN-γ. The role of anti-
fibrotic has been proved by studies which showed that local injections of IFN-γ 
reduce the contracture formation and facilitate mouth-opening.  The pro-fibrotic 
cytokines produced by these inflammatory cells can create an environment favoring 
fibrosis.24 
 
Increased collagen synthesis 
Fibroblast proliferation 
Studies have shown that areca nut causes fibroblast proliferation. OSF fibroblasts 
were found to have a doubling time of 3.2 days while for fibroblasts from normal 
mucosa it was 3.5 days. 25 
Increased collagen synthesis 
Collagen is the major structural component of the connective tissue and its 
composition needs to be maintained for proper tissue integrity. Three main events are 
modulated by TGF-β that favours collagen production23: 
a) Activation of procollagen genes: COL1A2, COL3A1, COL6A1, COL6A3 and 
COL7A1  
b) Elevation of procolagen proteinase levels: PCP and PNP 
c) Up-regulation of LOX  
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OSF fibroblasts show a 1.5 fold increase in the collagen production. Both normal and 
OSF fibroblasts produced 85% of type I and 15% of type III collagen. 
The ratio of α 1(I) pro-collagen to α 2(I) pro- collagen was 3:1 in OSF in contrast to 
2:1 as in normal. There is an over expression of pro-collagen mRNAs corresponding 
to the increased collagen production OSF. 25 
          Morphologically, fibroblasts were classified into three types: F1, F2 and F3.  
OSF fibroblasts showed an increase in the F3 population of fibroblasts when 
compared to F1 population, but normal mucosa had greater number of F1 than F3 
fibroblasts. F3 fibroblasts are large stellate shaped fibroblasts which are less 
proliferative and more collagen producing while F1 fibroblasts are spindle shaped, 
proliferative and less collagen producing. F2 fibroblasts are intermediate cells which 
are epitheloid in shape and are less proliferative than F1.10 
 
Reduced Collagen destruction 
Reduced fibroblast phagocytosis 
OSF fibroblasts exhibited a 40% reduction in the collagen phagocytic cells and 48% 
reduction in the fibronectin phagocytic cells. Interestingly normal fibroblasts also 
when exposed to areca alkaloids showed a dose dependent reduction in phagocytic 
abilities.26 
 
The two main events modulated by TGF-β which decreases the collagen degradation 
are23: 
a) Activation of tissue inhibitor of matrix metalloproteinasegene (TIMPs) 
b) Activation of plasminogen activator inhibitor (PAI)  gene 
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Clinical features  
Various investigators have correlated the salient clinical features and 
histological features. The onset is insidious over a period of 2-5 years.  OSF patients 
usually present with rigidity or inability to open the mouth and burning sensation on 
taking hot and spicy food. Appearance of blisters or vesicles, ulcers, petechiae, 
melanosis and xerostomia are the usual initial symptoms. The frequently affected sites 
are buccal mucosa, retromolar region, and soft palate. As the disease progresses, the 
mucosa becomes blanched along with presence of palpable fibrous bands. Sub-
mucosal fibrotic bands are palpable in buccal mucosa, labial mucosa, retromolar 
region and soft palate. Fibrosis of the soft palate can cause fixation, shortening and 
deviation of uvula. When tongue is involved it becomes immobile and depapillated. 
The dense fibrosis of the tissue around the pterygomandibular raphe is responsible for 
the varying degrees of trismus. 
Fibrosis may extend into the pharynx and pyriform fossae causing referred 
pain in the ear.14,  27 
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Fibroblast  
They are the predominant cells in the fibrous connective tissue. These cells are 
spindle shaped with oval nuclei having one or two minute nucleoli, eosinophilic to 
basophilic cytoplasm depending on the rate of synthetic activity. Fibroblasts are 
responsible for intracellular assembly of various extra cellular fibrillary and non 
fibrillary products such as, procollagen, pro-elastin and glycosaminoglycans. 
 
Fibroblast growth characteristics 
Hayflick L and Moorhead P.S (1961) isolated and characterized human diploid 
fibroblasts from fetal tissue and the cultured fibroblasts were subjected to 
chromosomal analysis to determine the polyploidy or diploid class of cells. Cultured 
diploid fibroblasts were seen to have three phases of growth. In the early growth 
phase or phase I, the cells freed from the tissue established themselves on the culture 
plate. This phase lasts for 1or 3 weeks and ends with the formation of a confluent 
plate. After the first subculture, it enters into phase II which is characterized by rapid 
cell multiplication. This phase lasts for 2-10 months. By the end of this time cell 
degeneration starts to take place. This is followed by the cell entering the phase III. 
This phase is characterized by less mitotic activity and increase in cellular 
degeneration.  
 They noted that there exists a finite limit for the cultivatable period for the 
human diploid fibroblast, which is approximately 50 subcultures or 250 cell 
generations. 
They also implanted diploid fibroblasts into hamster check pouches and 
homotransplanted the same on to terminal cancer patients. None of the transplanted 
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diploid cells were able to produce any evidence of growth while transformed HeLa 
cell lines inoculated in the same manner, grew.28  
 
Todaro G.J and Green H (1963) conducted a study where they disaggregated mouse 
embryo fibroblast cells and grew it in monolayers and were cultured at concentrations 
3 x 105 and 6 x105 cells per plate with a doubling time of 60 hours and 30 hours 
respectively. Between the 10th -20th generation, the growth of the cells declined and 
doubling time exceeded 70 hours. From the 15th -30th generation, the growth rate of 
cells rose again and reached to a value similar to the beginning. The culture was then 
considered established. 
This culture became tetraploid in later stages. The cells had the ability to grow 
in low concentration density (5x104) and showed a progressive increase in the 
saturation density. Cell morphology of early established lines was found to be similar 
to normal. The cells were able to form multilayers, in crowded cultures and these cells 
were shown to grow for 100 generations raising growth rate. They did not show any 
indication of growing out.29 
 
Schneider E.L and Mitsui Y (1976) conducted a study to evaluate the difference in 
the in vitro life span of fibroblast cultures derived from elderly (63-92 years) and 
younger (21-36 years) individuals. A decrease was found in the rate of migration, 
culture senescence and replicative capacity in the fibroblasts derived from older aged 
subjects. This decrease was found to be statistically significant. The percentage of 
replicating cells and saturation density were found to be 50% higher in fibroblasts 
derived from younger donors, but there was no statistically significant difference in 
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the seeding efficiency, cell volume or macromolecular contents in the fibroblasts 
derived from the two age groups.30 
  
Angello J.C, Pendergrass W.A, Norwood T.H and Prothero J (1989) performed a 
study to assess the increase in fibroblast cell size when cultured in low serum and low 
density conditions. For this, they cultured human diploid fibroblast (HDLF) like cells 
and chick embryo fibroblasts. It was observed that larger sized fibroblasts had lower 
replicative capacity. Cells cultured in low serum (0.1%) and high density produced 
smaller cells retained their potential to replicate. The large and small G1 cells were 
sorted and cloned. The small cells produced 10 progeny while the larger cells 
produced 4.3 progeny. These results helped to conclude that the ability of fibroblasts 
to replicate is directly proportional to cell size.31 
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Role of Areca nut in collagen production and the development of 
Submucous fibrosis 
 
Van Wyk C.W,Oliver A, De Miranda C.M,Van der Bijil P,Grobler-Rabie A.F 
(1994) conducted a study to observe the effects of areca nut extracts on cultured oral 
mucosal fibroblasts. For this they exposed the fibroblast cells to three different forms 
of areca nut - aqueous extracts of raw, baked and boiled, at concentrations of 0, 50, 
100, 150, 300 and 500μg/ml. The arecoline and arecaidine levels were also estimated 
using HPLC technique. They observed that at concentration as low as 50μg/ml, all 
extracts of areca nut inhibited oral fibroblast cell proliferation. At concentrations of 
50-150μg/ml, cell numbers remained constant or showed limited proliferation. Total 
cell-death was observed at concentrations between 
300-500μg/ml.32 
 
Jeng J.H, Kuo M.L, Hahn L.J and Kuo M.Y.P (1994) studied the effects of 
a) Betel nut alkaloid-arecoline, b) Betel quid constituents –betel nut (BN), 
inflorescence (IFN) and lime and c) Betel nut polyphenol –catechin, on cultured oral 
fibroblast cells. They observed that arecoline, catechin, extracts of betel nut and 
inflorescences were cytotoxic in a dose dependent manner, while lime at 
concentrations 500-800 μg/ml increased the cell proliferation. It was also found that 
betel nut (BN), inflorescence (IFN) extracts induced DNA break up. Inspite of 
arecoline and catechin being cytotoxic, they didn’t produce any DNA break up. 
Among the antioxidants, glutathione and cystine had cyto-protective effect against 
areca nut induced cytotoxicity.33 
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Kuo M.Y.P, Chen H.M, Hahn L.J, Heish C.C and Chiang C.P (1995) studied 
collagen biosynthesis from OSF fibroblasts. OSF fibroblasts showed a 1.5 fold 
increase in the collagen production. Both normal and OSF fibroblasts produced 85% 
of type I and 15% of type III collagen. The ratio of pro collagen α 1(I) to pro collagen 
α 2(I) was 3:1 in OSF in contrast to 2:1 in normal. This presence of excess of pro 
collagen α 1(I) in OSF indicates the presence of collagen molecules composed 
entirely of pro collagen α 1(I) which is more resistant to degradation. This type of 
collagen accounts for 25% of the type I collagen produced by OSF fibroblasts. 34 
 
Van Wyk C.W,Oliver A, Helden E.G H,Grobler-Rabie A.F (1995) conducted a 
study to evaluate and compare  the proliferation of oral fibroblasts and skin fibroblasts 
from OSF patients and normal controls. The fibroblast cells were obtained from 
fibrous bands present on the buccal mucosa and the inner aspect of the forearm of 
patients with OSF as well as from healthy non-areca nut chewing individuals. They 
observed at concentrations of 0.1-10.0μg/ml, the cell exposed to arecoline followed a 
normal proliferation pattern, except for the oral fibroblasts of OSF patients which 
were slightly depressed. Cell growth was inhibited at the concentration of 400μg/ml. 
the morphology of cells from both skin and buccal mucosa was comparable to the 
spindle-shaped F1 fibroblast, epithelioid FII cells. Spindle-shaped fibroblasts 
dominated in both skin and mouth cell-cultures on day 6.13 
  
Ma R.H, Tsai C and Sheih T.Y (1995) compared the population doubling time of 
OSF fibroblasts with normal controls. The found that OSF fibroblasts had a doubling 
time of 3.2 days while for normal controls it was 3.5 days. They also observed that 
both protein content and lysyl oxidase activity was higher for OSF fibroblasts when 
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compared to normal fibroblasts. The immunoenzymatic assay for BrdUrd 
incorporation revealed that OSF fibroblasts proliferate significantly faster than NM 
fibroblasts under standard culture conditions. Both total protein content (10.84±1.15 
mg/ml) and lysyl oxidase activity (3558.6±345.5 cpm/106 cell) in OSF fibroblasts 
were greater than in NM fibroblasts (6.35±0.96 mg/ml and 2436.0±352.6 cpm/106 
cell).25 
 
Jeng J.H, Lan W.H, Kuo M.L, Hahn L.J, Heish C.C and Kuo M.Y.P (1996) 
demonstrated the association of betel quid chewing and gingival health. The study 
was carried out by studying human gingival fibroblast (HGF) when exposed to 
arecoline. At concentrations higher than 0.4mM, inhibited cell attachments, cell 
spreading; cell migration in a dose dependent manner. It was considered to be due to 
the intracellular depletion of glutathione. 24 hour incubation of cells with 1 mM of 
arecoline left only 35% cells viable.35 
 
De Waal J, Van Wyk C.W, Oliver A and Martiz J.S (1997) compared the 
morphology of fibroblasts cultured from healthy oral mucosa and mucosa of patients 
with OSF. They also collated the occurrence of cell types of similar morphology.  
OSF fibroblasts showed an increase in the F3 population when compared to F1 
population following an 8 day observation period. They found that F3 fibroblasts 
which were large stellate shaped cells as compared to F1 fibroblasts which were 
spindle shaped cells. F2 fibroblasts were epitheloid cells having intermediate 
characters.10 
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Chang Y.C, Tai K.W, Cheng M.H, Chou L.S.S and Chou M.Y (1998) performed  
cytotoxicity and genotoxicity assays to investigate the pathobiological effects of 
arecoline on cultured human buccal  fibroblasts. Arecoline increased  
polynucleic acids at a concentration of 0.1to 10 μg/ml in a dose dependent manner. 
At a concentration higher than 50μg/ml, arecoline was cytotoxic to the cultured 
fibroblasts. Genotoxicity was not observed even with concentrations as high as  
400μg/ml of arecoline .On the other hand, glutathione (at 600 μg/ml) and glycyrrhizin 
 (at 200 μg/ml)   were found to have cyto-protective effects against arecoline. These 
results indicated that arecoline was a cytotoxic agent and not genotoxic to human 
fibroblasts. Increased consumption of glutathione and glycyrrhizin rich food was 
found to reduce the oral diseases associated with betel-quid chewing. 36 
 
Tsai C, Ma R.H and Sheih T.Y (1999) cultured fibroblasts from OSF and normal 
subjects. Collagen and fibronectin coated beads were incubated in normal and OSF  
fibroblast cultures for 16 hours to assess their phagocytic abilities. OSF fibroblasts 
exhibited a 40 % reduction in the collagen phagocytic cells and 48% reduction in the 
fibronectin phagocytic cells. Normal fibroblasts when exposed to areca alkaloids 
showed a dose dependent reduction in phagocytic abilities.37 
 
Chang Y.C, Hu C.C, Tseng T.S, Tai K.W, Lii C.K and Chou M.Y (2001) 
demonstrated that arecoline at concentrations higher than 50μg/ml was cytotoxic to 
fibroblasts in a dose dependent manner. Also, it was seen that arecoline significantly 
decreased the GST activity, but it did not increase lipid peroxidation .the addition of 
extracellular nicotine acted synergistically on the arecoline-induced cytotoxicity. 22 
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Trivedy C, Meghi S, Warnakalasuriya K.A.A.S, Johnson N.W, Harris (2001)  
Incubated fibroblasts with 0.1 to 500μM of CuCl2 .The fibroblasts showed an 
increased collagen production. There was no increased non collagenous protein 
production or cell proliferation.20 
 
Sheih D.H, Sheih T.Y, Chiang L.C (2003) conducted a study to assess the cytoxic 
role of arecoline, arecaidine and safroline in betel-quid and to quantify the TIMP-1 
expression. Both normal and OSF fibroblasts cells were cultured from the same 
patient. OSF fibroblasts produced more tissue inhibitor for matrixmetallo protease I 
(TIMP-1) protein than normal fibroblasts. They concluded that increased mRNA 
expression of TIMP-1 in buccal mucosal fibroblast by arecoline and safrole has a 
possible role in the pathogenesis of OSF.38 
 
Sheih D.H, Chiang L.C, Lee C.H, Yang Y.H and Sheih T.Y (2004) carried out a 
study to investigate the effects of arecoline, safrole and nicotine on cultured 
fibroblasts obtained from tissue specimen from the buccal mucosa of OSF patients 
and healthy controls. They found that the phagocytic activity of OSF fibroblasts and 
normal fibroblasts were inhibited in a dose dependent manner on exposure to 
arecoline, safrole and nicotine.26 
 
Tsai C.I, Yang S.F, Yang Y.J, Chu, IIseih Y.S and Chang Y.C (2004) studied m 
RNA expression of IL-6 in the cultured fibroblasts from OSF patients and buccal 
mucosal fibroblasts from normal controls (NBM). The IL-6 expression in OSF 
fibroblasts was found to be elevated. Fibroblasts from normal buccal mucosa showed 
a raised IL-6 expression when exposed to arecoline in a dose dependent manner. In 
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order to determine the role of intercellular glutathione (GSH) levels on IL-6 levels in 
NBM fibroblasts, NBM fibroblasts were pretreated with GSH elevating agent 2-
Oxothiazolidine-4-Carboxylate (OZT) and a GSH reducing agent Buthione 
sulfoxamine (BSO) and was exposed to arecoline. The IL-6 levels were determined. 
In NBM fibroblasts arecoline induced 2.7 folds of IL-6 mRNA expression while BSO 
pretreated fibroblasts showed an increase in IL-6 activity by 3.4 folds. The cells 
pretreated with OZT showed only a marginal increase of 1.7 fold in IL-6 activity. 39 
 
Fibroblast heterogeneity  
Castor et al in 1960 conducted the first study on fibroblast heterogeneity where they 
assessed the different fibroblasts cultures from dermis articular tissue, mesothelial 
surface & periostium. They found that mesothelial fibroblasts had a slower 
proliferation rate and produced more acid mucopolysacchride than other fibroblasts. 
Fibroblasts are not homogenous as they differ in their morphology and function 
because fibroblasts in different tissues and organs have varied function 40 
 
Mitsui Y and Schneider E.L (1976) considered human fetal lung fibroblasts (WI 
168) cell lines which were in three different phases of culture to assess the cell 
replicative potential. The different phases observed were  in the early passage (cells at 
19 population doublings), middle passage (cells at 35 population doublings) and late 
passage (cells at 47 population doublings) based on cell size by gravity 
sedimentation.[3H] TdR labeling was done to assess its replicative potential. 
They observed that late passage cells yielded cell population enriched for large 
cell volume and slow replication. Fibroblast cells seen in the early and middle 
passages were small and had faster replicative potential. When re-introduced into 
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tissue culture conditions, cell populations lost their phase properties and resembled 
the un-fractionated cell culture at the same level of in vitro passage.41 
 
Harper R.A, Grove G (1979) carried out fibroblast culture on human dermis to study 
their saturation level and population doubling time. Human dermis is divided 
histologically into two layers, upper papillary dermis and lower reticular dermis. It 
was found that papillary dermis was metabolically active and had more fibroblasts 
than reticular dermis. On culturing fibroblasts from papillary dermis and reticular 
dermis separately from the same patient; it was found that saturation level and 
population doubling time of papillary dermis fibroblasts were always higher than in 
reticular dermis fibroblasts. 
Atrophy of the papillary layer of skin was observed with aging, so a full 
thickness skin culture will have more reticular fibroblasts than papillary fibroblasts 
resulting in less replicative short lived fibroblast cultures compared to cultures from 
tissues of younger individuals.42 
 
Smith J.R, Whitney R.G (1980) cultured human embryonal lung fibroblasts in vitro 
and found that there was heterogeneity in the proliferative potential which appears 
rapidly within a single clone of cells. 
  Cultures from a single cell after 16 population divisions (PD) had cells with 
doubling potential ranging from 0-33 PDs whose distribution curve was bimodal. Two 
cells from the same mitotic event can differ by as many as 8 PDs.43 
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Mollenhauer J and Bayreuther K (1986) studied rat skin and lung fibroblasts and 
based on their morphological differences found three subpopulations F I, FII, F III. 
 FI cells are diploid, spindle shaped and highly proliferative. and synthesize low levels 
of type-I and -III collagen. FII cells are also diploid epithelioid shape, proliferate 
slowly, and produced more collagen as compared to FI cells. FIII fibroblasts are large, 
stellate, tetraploid cells that proliferate more slowly than the other types but 
synthesize large amounts of collagen. 11 
 
Somerman M.J, Archer S.Y, Imm G.R and Foster R.A (1988) evaluated 
periodontal ligament and gingival fibroblasts from the same patient for heterogeneity 
even though they were similar in morphology and proliferation rates. 
 Early passage periodontal ligament fibroblasts showed contact inhibition but 
not gingival fibroblasts. Periodontal ligament fibroblasts showed more protein 
production and alkaline phosphatase activity than gingival fibroblasts.44 
 
Bayreuther K, Rodemann H.P ,Hommel R, Dittmann K, Albiez M and Francz 
P.I (1988) found that further differentiation occurred along the terminal cell lineage 
with mitotic fibroblasts, F-I, F-II, F-III. It was observed in culture studies that when 
the mitotic capacity of F-III is exhausted, they become post-mitotic and differentiate 
into cell-lineage sequences following the mitotic sequence as F-IV, F-V, F-VI and 
degenerating fibroblast F-VII. F-I is a small spindle shaped cell. F-II is a small 
epitheloid cell. F-III is a large pleomorphic epitheloid cell. F-IV is a large spindle 
shaped cell. F-V is a larger epitheloid cell. F-VI is the largest epitheloid cell of the 
fibroblast series and F-VII is the degenerating fibroblast.12 
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Kawase T, Sato S, Maike K and Saito S (1988) conducted a study to assess the 
alkaline phosphatase activity on different cells associated with the dentition. For this 
they studied alkaline phosphatase activity of human periodontal ligament fibroblast 
(HPLF), human alveolar bone cells (HABC) and gingival fibroblasts. They observed 
that alkaline phosphatase synthesized by HPLF were similar to HABC and that 
gingival fibroblasts had no alkaline phosphatase activity. They also observed that 1, 
25 di (OH) cholicalciferol can markedly stimulate alkaline phosphatase activity in 
HPLF and HABC and also that  it had no effect on gingival fibroblasts. As HPLF’s 
alkaline phosphatase activity is similar to HABC, HPLF can also be termed as 
osteoblastic fibroblasts. 45         
          
Oslen D.R, Peltonen J, Jaakkola S, Chu M.l and Uttio J (1989) carried out a study 
on human skin fibroblasts to assess their ability to synthesize genetically distinct 
procollagens. Their study revealed the presence of mRNA transcripts for collagen 
types I, III, IV, V and VI but not for collagen II. It was also observed that mRNA 
expression for type I and VI was highest and for type V and IV lowest. 
The homogeneity of skin fibroblasts with regard to procollagen gene 
expression was shown as the individual fibroblasts were found to be capable of 
expressing multiple procollagen genes. 46 
 
Breen E, Falco V.M , Absher M and Cutroneo K.R (1990) conducted experiments 
where they isolated different types of fibroblasts depending upon the type of collagen 
coating on the cell surface. They were able to derive two sub populations from the 
Human Lung Fibroblasts by means of Fluorescent Assisted Cell Sorting (FACS). 
They identified that one of the sub populations had cells with type I collagen surface 
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coating in association with more of type I procollagen mRNA while the other sub 
population had cells with type III collagen surface coating in association with type III 
procollagen mRNAs.  These fibroblast subgroups were able to maintain their 
phenotype even after four subcultures. 47  
 
Goldring S.R, Stephenson M.L, Downie E, Krane S.M, and Korne J.H (1990) 
studied the fibroblast heterogeneity in matrix biosynthesis and response to 
parathormone and prostaglandin E2. Fibroblasts were cultured from three skin 
samples and 24 cloned sub strains were made. 
Sub strains from two parent samples were shown to be responsive to 
prostaglandin E2 and parathormone indicated by an increase in the C-AMP levels. 
The third parent culture was responsive to parathormone but none of its clones were 
responsive but all clones were responsive to prostaglandin E2.                                   
          All sub strains produced type I and type III collagen with variation in the 
amounts. Correlation was found between steady state levels of α 1(I) pro collagen 
mRNA and incorporation of [3H] proline into α 1(I) pro collagen chains. Levels of 
type I and type III pro collagen mRNAs showed positive correlation indicating a 
similar coordinate regulation of type I and III collagen gene expression.48 
 
Sempowski G.D, Derdak S and Phipps R.P (1996) carried out tests to evaluate the 
collagen production from fibroblasts when subjected to different environments. They 
found that IL-4 induced 100% increase in the collagen production in Thy-1+ 
fibroblasts while no effect was there on Thy-1- fibroblasts collagen production. The 
collagen production was reduced by 50% in both Thy-1+ and Thy-1-   in presence of 
IFN-γ. A slight increase in the collagenase activity was seen in Thy-1+ fibroblasts on 
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exposure to IFN-γ but not present in Thy-1- fibroblasts. There was increased 
expression of Tissue inhibitor of matrixmetallo protease (TIMP) in both subtypes 
more in Thy-1- fibroblasts on exposure to IL-4 or IFN-γ.49 
 
Sorrel J .M, Baber M.A, Caplan A.I (2006) demonstrated a study to assess 
fibroblast heterogeneity within a region of dermis (epidermis and papillary dermis) 
for which skin at a depth of 40μm was selected. Cells released by enzymatic digestion 
were cloned by limited dilution. Initial selection was based on morphotype and 
proliferation pattern of the cells. These clones of cells isolated by limited dilution 
were found to be different in their rate of collagen lattice contraction, ability to 
organize fibronectin matrix and release of specific growth factors and interleukins. 50 
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High Performance Liquid Chromatography in analysis of the Areca 
nut products: 
              Chromatography is the term used to describe a separation technique in which 
a mobile phase carrying a mixture is made to move in contact with a selectively 
absorbent stationary phase. The mobile phase is a solvent which is pumped under high 
pressure through a column. The stationary phase is a finely divided solid held inside 
the column. Different components of the sample are carried forward at different rates 
by the moving liquid phase, due to their differing interactions with the stationary and 
mobile phases. There are a number of different kinds of chromatography, which differ 
in the mobile and the stationary phase used.                                       
           HPLC is a chemistry based tool for quantifying and analyzing specific 
chemical compounds within the mixture. The sample is dissolved in a solvent (like 
water or alcohol) and thus the term liquid chromatography. A detector measures 
response changes between the solvent itself and the solvent and sample when passing 
through it. The electrical response is digitized and sent to a data system.  
Simona Pichini, Manuela Pellegrini, Roberta Pacifici, Emilia Marchei, 
Janeth Murillo, Carme Puig, Oriol Vall and Oscar Garcı´a-Algar (2003) carried 
out a study to assess the eventual fetal exposition to arecoline by the analysis of 
neonatal biological matrices. A high performance liquid chromatography (HPLC) 
method with mass spectrometric detection was described for determination of 
arecoline in newborn meconium, urine and cord serum using pilocarpine as internal 
control. The samples were analyzed by HPLC coupled to an electrospray (ESI) 
interface and a quadrupole mass spectrometer. Chromatography was performed on a 
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C8 reversed-phase column using 10mM ammonium acetate (pH 4.3)/acetonitrile 
(90:10, v/v) as mobile phase. The method was validated over the concentration range 
0.))%-1.00µg/g meconium, 0.004-1.00µg/mL cord serum and 0.001-1.00µg/mL urine. 
The mean recoveries ranged between 86.5 and 90.7% for arecoline in different 
biologic matrices, with precision better than 10%.51 
 
Stephen Cox, Irina Piatkov, E.Russell Vickers, Gary Ma (2004) conducted a study 
employing HPLC method for determination of arecoline in saliva, using arecaidine as 
internal control. The optimal ultraviolet wavelength was shown to be 215nm for 
detecting arecoline in the mobile phase. Arecoline was extracted from saliva with 
hexane-isoamyl alcohol (1%) and reconstituted with mobile phase for HPLC. They 
proved that HPLC is a reliable, cost-effective and efficient method for the 
determination of arecoline concentration in saliva.52 
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Data analysis was done using SPSS (Statistical package for social science) version 14. 
 
Linear regression analysis was performed  
• To derive the slope from growth curves of each cell line. 
 
Correlation coefficients were determined to analyze 
• The F1, F2 and F3 ratios in each cell line and between each group. 
• Mitotic cell to post mitotic cell ratios in each cell line and between each group. 
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 This study was carried out to assess the phenotypic and proliferative 
alterations in the cultured fibroblasts obtained from the buccal mucosa of patients 
without any chewing habits when exposed to a commercially available areca nut 
product extract.  
 
Buccal mucosal fibroblast cell lines were established from six subjects. The 
subject inclusion criteria were subjects who do not have the habit of chewing areca 
nut and have clinically normal appearing oral mucosa, i.e., n=3 (Control group) and 
n=3 (Study group). 
 
The clinical history and cell line designations of the study subjects are given in 
(Table1). Buccal mucosal fibroblasts from the subjects were grown in complete 
media, on reaching confluency they were subcultured. In the study group, the 
fibroblast cells were exposed to areca nut extracts while the control group was 
cultured without exposing them to any areca nut forms. 
 
Growth curve was plotted for the control group and population doubling time 
and seeding efficiency was derived from the slope to characterize the normal buccal 
fibroblast. (Table 5, 9, 13). 
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Extraction yield from Areca nut product: 
80gm of a commonly used commercial areca nut product was subjected to hydro-
alcoholic extraction and a yield of 21% was obtained. (Table  2). 
 
 
HPLC analysis of arecoline and arecaidine in reference: 
Samples of arecoline (Sigma TM) and arecaidine (Sigma TM) were subjected to HPLC 
and the concentration level of arecoline was 20.538µg/ml and the concentration of 
arecaidine was 15.932µg/ml. (Table 3). 
 
 
HPLC analysis of arecoline and arecaidine in extract of areca nut product: 
The extract obtained, after hydro-alcoholic extraction of the areca nut product, was 
subjected to HPLC and the concentrations of arecoline was 11.638µg/ml and 
arecaidine concentration was 761.808µg/ml. (Table 4). 
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GROWTH CURVE, F1:F2:F3 FIBROBLAST SUBPOPULATION  RATIO,  
MITOTIC: POST-MITOTIC FIBROBLAST  
SUBPOPULATION  RATIO. 
 
Control Group 
1st Normal mucosa cell line (1 NB) 
Growth curve and its derivatives (Graph 3, Table 5)    
The initial seeding concentration was 12 x103 cells/ well/ ml. There was a loss of cells 
within 12 hours of attachment time. The seeding efficiency was 58.3 %. There was a 
gradual increase in the slope of the growth curve from day 3 to day 8. Population 
doubling time calculated from the slope of the graph was 43.08 hours. Plateau phase 
was reached by the 4th day of the culture.  
 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 4, Table 6,7 )  
There was an increase in F2 (p<0.05) and F3 (p>0.05) subpopulation of fibroblast 
during an 8 day observation period. On the contrary, F1 subpopulation (p<0.01) 
showed a decrease during the observation period. 
 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 8, 28) 
There was a decrease in the mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with post-mitotic fibroblast subpopulation, and the 
change was statistically significant. 
There was an increase in the post-mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with mitotic fibroblast subpopulation and the 
change was statistically significant. 
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2nd Normal mucosa cell line (2 NB) 
Growth curve and its derivatives (Graph 4, Table 9)  
The initial seeding concentration was 12 x103 cells/ well/ ml. There was a loss of cells 
within 12 hours of attachment time. The seeding efficiency was 50%. There was an 
increase in the slope of the growth curve from day 1 to day 6. Population doubling 
time calculated from the slope of the graph was 36.12 hours.  
 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 5, Table 10, 11)  
During the 8 day observation period, an increase in the fibroblast subpopulation of F2 
(p<0.000) and F3 (p>0.05) was seen. Decrease in F1 fibroblast subpopulation 
(p<0.000) was also noted during this period. 
 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 12,28) 
There was a decrease in the mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with post-mitotic fibroblast subpopulation, and the 
change was statistically significant. 
There was an increase in the post-mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with mitotic fibroblast subpopulation and the 
change was statistically significant. 
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3rd Normal mucosa cell line (3 NB) 
Growth curve and its derivatives (Graph 6, Table 13)  
The initial seeding concentration was 12 x103 cells/ well/ ml. There was a loss of cells 
within 12 hours of attachment time .The seeding efficiency was 50 %. There was a 
steady increase in the slope of the growth curve from day 1 to day 7. Population 
doubling time calculated from the slope of the graph was 22.85 hours.  
 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 7, Table 14, 15)  
An increase in the F3 subpopulation of fibroblast (p<0.01) during an 8 day 
observation period along with an increase in the F2 subpopulation of fibroblast 
(p>0.05) was seen. There was a decrease in the F1 subpopulation of fibroblast 
(p<0.01) during the observation period. 
 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 16,28)  
There was a decrease in the mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with post-mitotic fibroblast subpopulation but the 
change was not statistically significant.  
There was an increase in the post-mitotic fibroblast subpopulation during an 8 day 
observation period in comparison with mitotic fibroblast subpopulation but the change 
was not statistically significant. 
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Study Group 
4th Normal mucosa cell line (4 NB) 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 8, Table 17, 18)  
There was an increase in the F3 subpopulation of fibroblast (p<0.01) during a 5 day 
observation period along with an increase in the F2 subpopulation of fibroblast 
(p<0.05) was seen. There was a decrease in the F1 subpopulation of fibroblast 
(p<0.001) during the observation period. 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 19,28)  
There was no post mitotic fibroblast subpopulations observed during the 5 day 
observation period. 
 
5th Normal mucosa cell line (5 NB) 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 9, Table 20, 21)  
During the 5 day observation period, an increase in the F3 subpopulation of fibroblast 
(p>0.01) along with an increase in the F2 subpopulation of fibroblast (p<0.05) was 
seen. There was a decrease in the F1 subpopulation of fibroblast (p<0.05) during the 
observation period. 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 22,28 )  
There was no post mitotic fibroblast subpopulations observed during the 5 day 
observation period. 
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6th Normal mucosa cell line (6 NB) 
F1:F2:F3 Fibroblast subpopulation ratio (Graph 10, Table 23, 24)  
An increase in the F3 subpopulation of fibroblast (p>0.01) during the 5 day 
observation period along with an increase in the F2 subpopulation of fibroblast 
(p>0.05) was seen. There was a decrease in the F1 subpopulation of fibroblast 
(p<0.01) during the observation period. 
 
Mitotic: Post-mitotic fibroblast subpopulation ratio (Table 25,28)  
There was no post mitotic fibroblast subpopulations observed during the 5 day 
observation period. 
 
 
 
 
 
 
47 
 
Over the years, OSF, a crippling, irreversible disease of the oral mucosa, has 
gained importance among the dental professionals in different parts of the world. 
Various studies, epidemiological and case-reports have shown that the peculiarity of 
this disease is that it is confined to particular geographic regions, especially the Indian 
sub-continent and South Africa. These findings have led to the concept that dietary or 
cultural habits prevalent in these regions could act as the aetiological factor.  
  OSF is characterized by fibrosis of the submucosa.53  On exposure to various 
alkaloids of areca nut, there is an accumulation of inflammatory cells at the 
submucosal region which selectively induce high collagen producing fibroblast 
phenotype.54 Fibroblasts are a heterogeneous group of cells whose morphology and 
function varies depending on the local environment.46 Exposing normal fibroblasts to 
various areca nut products in cultures or growing the altered fibroblast directly from 
the pathologic site and studying their characteristics is a valuable tool in our 
understanding of the disease. 
In the last few decades, small and attractive sachets of betel quid substitutes 
have become widely available in India and are found to be very popular among the 
younger age group. These products are flavored and sweetened dry mixture of areca 
nut, catechu and slaked lime with tobacco (gutka) or without tobacco (pan masala). 
These products have been strongly implicated in the incidence of OSF, even with a 
short period of use. As gutka and pan masala are mixtures of several ingredients, the 
role players in the resulting disease are yet to be studied. Reviewing various 
literatures on the pathogenesis of OSF, we identified the alkaloids to play a major role 
in pathogenesis of OSF. 
In our study we cultured fibroblasts from the buccal mucosa of patients without   
chewing habits or existing oral lesions to assess the effects of areca nut products on 
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them. 80gm of a commercial areca nut product was subjected to hydro-alcoholic 
extraction and the yield was 21%.(Table 2).In HPLC, retention peak areas and 
ultraviolet absorption spectra were used to identify and quantify arecoline and 
arecaidine in the areca nut product. The chromatography was performed using two 
different mediums. Deionized water was used because it is used in cell cultures 
medium in which the exposure was done. Phosphated buffer saline (PBS) was used as 
the other medium because it is similar to the human saliva and its pH was adjusted to 
HPLC optimal level of 7.8.52Arecaidine concentration was found to be 761.808µg/ml 
and arecoline concentration 11.638 µg/ml in phosphated buffer saline (PBS).(Table 4) 
In deionosed water the arecoline concentration was 3.490 µg/ml and arecadine was 
716.736 µg/ml.  
  To assess the effects of areca nut product on cultured normal buccal fibroblast, 
three cell lines were exposed to the areca nut extract and compared with the non-
exposed control cell-lines. The shifts in the fibroblast phenotypes were studied based 
on the subpopulation model used by de Waal J et al in 1997 14 on OSF fibroblasts  as 
F1,F2 and F3 and fibroblast subpopulation model developed on human skin 
fibroblasts by Bayreuther et al in 1988 as mitotic and  post mitotic.20  
 The description of buccal mucosal fibroblast subpopulations as F1, F2, F3 
were based on the fibroblast subpopulation description done by Mollenhauer and 
Bayreuther in 1986 on rat skin fibroblasts.11 In 1988 Bayreuther et al described 
human skin fibroblasts.12 They found that subpopulations of mitotic fibroblasts (F1, 
F2, and F3) during the course of growth exhaust their mitotic abilities and becomes 
post-mitotic phenotypes (F4, F5, F6 and degenerating fibroblast F7). F1 is a small 
spindle shaped cell. (Fig 12) F2 is small epitheloid. (Fig 13)  F3 is large pleomorphic 
and epitheloid. (Fig 14)  F4 is large spindle shaped. (Fig  15)  F5 is larger epitheloid, 
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larger than F3. (Fig 16)  F6 is the large epitheloid, larger than F5. (Fig 17) and F7 is 
the degenerating fibroblast. (Fig 18)11          
In  1997 de Waal J et al described buccal mucosal fibroblasts as belonging to 
three subpopulations namely F1 fibroblasts which are spindle shaped, highly 
proliferative and low collagen producing phenotype, F2 fibroblasts which are 
epitheloid, less proliferative and produce relatively higher amount of collagen and F3 
fibroblasts that are stellate shaped, least proliferative and high collagen producing 
phenotype. They found a relative increase in the F3 cells when compared with F1 
cells in OSF; this change was significantly larger than the controls.10 
 When the control group buccal mucosal fibroblasts subpopulations were 
analyzed for eight days, the last three days did not show any significant variation, 
hence the subpopulation was analyzed for only five days in both study and control 
groups. When the subpopulation were analyzed as F1,F2 and F3, we found a 
significant increase in F3 and F2 concentrations and a decrease in F1 concentration in 
both controls and study group. (Table 27) There was an increased trend in the F3 and 
F2 concentration in controls when compared to exposed group. Post mitotic 
fibroblasts were not observed in the exposed group when the subpopulations were 
analyzed using subpopulation model developed on human skin fibroblasts by 
Bayreuther et al11. This shows that there is an increased concentration of mitotic 
fibroblasts in exposed groups. The absence of post mitotic cells in the areca nut 
extract exposed cell lines could be because of the stimulation of cells by the areca 
alkaloids. The exposed extract contained 0.175µg/ml of arecoline. (Annexure I) This 
concentration of arecoline is found to increase the proliferation of fibroblast in earlier 
studies. Harvey W. et al (1996)55 noted an increase in proliferation in fibroblast cells 
when exposed to arecoline and arecaidine of concentrations of 0.1µg/ml, 1 µg/ml and 
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10 µg/ml. J.H Jeng et al (1994)33 had also showed a 20-40% increase in proliferation 
of cells in the presence of lime.  
 The increase in proliferation of fibroblasts in the exposed group may lead to 
exhaustion of mitotic potential and resulting in senescence and increased collagen 
production, and eventually leading to OSF. 
 In our study, fibroblast cells of patients without chewing habits showed an 
increased proliferation when exposed to areca nut product extract at a lower 
concentration when compared to the control group.  This shows that areca nut 
exposure at very low concentrations on fibroblast can alter their cellular function, 
leading to pathology. 
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• The present study was undertaken to evaluate the effects of areca nut on 
cultured human buccal fibroblasts from subjects without areca nut chewing 
habits. 
• Determination of F1:F2:F3 fibroblast subpopulation ratios, Mitotic: post 
mitotic fibroblast subpopulation ratios, growth curve with its derivatives were 
done to characterize the isolated fibroblasts. 
• We estimated the concentration levels of arecoline and arecaidine in a 
commercially available areca nut product using HPLC. 
• There was in an increase in post mitotic fibroblast and a decrease in mitotic 
fibroblast in the control group which was not statistically significant. 
• Post mitotic cells were not observed on exposure to low concentration of areca 
nut extract (0.175µg/ml) in five days of observation. 
• We found that there is an increase in F3 and F2 subpopulation (p<0.001) and a 
decrease in F1 subpopulation (p<0.001) within the control and study group. 
• We found that there is an increased trend in F3 and F2 subpopulations of cells 
in controls when compared to the study group. 
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Annexure I 
• One sachet packet of commonly used commercial areca nut product contains 
1.8gm 
• Yield during extraction process for the areca nut product is 21% (Table 2) 
• The amount of extract obtained from the areca nut product = 1.8 x 21 / 100 
                                                                                      = 0.378gm of extract 
• Amount of arecoline estimated for the commercial areca nut product in 
deionozed water by HPLC 
• 1µg/ml of the extract = 3.490µg/ml of arecoline 
 = 0.00349 µg/µl of arecoline 
• Percentage of arecoline in the extract = 0.00349 x 100 / 1 
    = 0.3% 
• One packet of commercial areca nut product = 1.8gm 
• Extract from 1.8gm of product                      = 0.378gm 
• Amount of arecoline in 0.378gm of extract = 0.378 x 0.3 / 100 
            = 0.00013gm 
            =1130µg of arecoline 
• Amount of arecoine estimated for the commercial areca nut product in PBS 
whose pH adjusted to saliva (pH 7.8) = 11.638µg/ml 
   = 0.011638 µg/µl of arecoline  
        (Table 4, Graph 2) 
 
• Percentage of arecoline from 1µg of extract in PBS  
= 0.011638 x 100 / 1 
= 1.16% 
64 
 
 
• One packet of commercial areca nut product = 1.8gm 
• Extract from 1.8gm of product = 0.378gm 
• Amount of arecoline in 0.378gm of extract in PBS = 0.378 x 1.16 / 100 
  = 0.00438gm 
  = 4380µg of arecoline 
• The amount of arecoline leached out from 1.8gm of product (extract weight 
0.378gm) 
= 0.00438gm of arecoline 
• Percentage of arecoline leached out in deionized water = 0.3% 
• The amount of extract to be added to the culture media to simulate saliva 
= 0.00438 / 0.3 x 100 
= 1.46gm 
• Cells were exposed to 1µl of 1.46gm dissolved in 5ml media 
• Amount of arecoline in 1ml media                        = 4380µg / 5 
 = 875µg 
• The amount of arecoline in 1 µl = 875 µg / 1000   = 0.875 µg 
 
• 1µl was added to the 5ml media of a fibroblast culture plate 
• Amount of arecoline in 1ml of media                = 0.875 µg / 5ml 
                                                                                             = 0.175 µg/ml of arecoline 
 
  
                                  
               Figure 4: pH meter                                                           Figure 5: Cyclo‐mixer. 
 
 
 
 
                           
     Figure 6: Electronic weighing balance.                                             Figure 7: Centrifuge. 
 
                    
        
               Figure 1: Phase contrast microscope                         Figure 2: CO2 incubator. 
 
 
 
                Figure 3: Laminar flow. 
 
                                                                                  
 
Figure 8: ‐20 °C Freezer. 
 
 
        Figure 9: Hot air oven. 
 
 Figure 10: Cell culture armamentarium. 
 
Figure 11: Cell culture reagents. 
                     
                        Figure 12                                    Figure 13  Figure 14 
                         F1 fibroblast (20X)                  F2 fibroblasts (20X)                F3 fibroblasts (40X) 
 
                                               
                                                 Figure 15                                       Figure16 
                          F4 fibroblasts (40X)                   F5 fibroblast (40X) 
 
                                                
                                 Figure 17                                   Figure 18 
                                  F6 fibroblast (40X)                            F7 fibroblast (40X)               
 
 
     
 
 
 
 
